New formulations Drug Approvals New drugs Trending Topics Oct. 20, 2025 – glycerol phenylbutyrate (Ravicti) Par/Endo launched a generic oral liquid to Horizon’s Ravicti Nitrogen-binding agent;...

The CDC is reporting influenza-like illness (ILI) for the week ending March 15, 2025 (week 11). Seasonal influenza activity remains increased across the U.S. but has decreased for five consecutive...

Managed Healthcare Executive: Prior authorization using integrated medical claims data helps diabetes patients get medications faster, with two-thirds processed automatically by July 2025 in this...

Gene therapy harnesses the body’s capacity to heal itself

Footnotes HighTouchRx has achieved a 50 Net Promoter Score (NPS).2 HighTouchRx was a Gold Award recipient at the AMCP Annual Meeting 2024, recognized for delivering an average savings of $73,142...

PUBLICATIONS FDA Decisions Expected: January 2026 Your monthly synopsis of new drugs expected to hit the market All brand names are property of their respective owners. References SERENA-6 trial:...

Oct. 29, 2025 – denosumab-desu (Jubereq) BLA approval; the 120 mg/1.7 mL single-dose vial for SC use has received FDA approval as an interchangeable biosimilar to the same presentation of denosumab...

Prime Therapeutics Report shares more about single-treatment gene therapies and proper management

From next-gen CFTR modulators to gene therapy and real-world drug impact, cystic fibrosis care is constantly evolving. Maryam Tabatabai, PharmD, of Prime Therapeutics, explains how innovative...

Annual meeting will feature industry research posters and educational sessions